Rüegg Ladina, Vonzun Ladina, Zepf Julia, Strübing Nele, Möhrlen Ueli, Mazzone Luca, Meuli Martin, Ochsenbein-Kölble Nicole
Department of Obstetrics, University Hospital Zurich, Rämistrasse 100, 8091 Zurich, Switzerland.
Faculty of Medicine, University of Zurich, Rämistrasse 71, 8006 Zurich, Switzerland.
J Clin Med. 2024 Aug 25;13(17):5029. doi: 10.3390/jcm13175029.
Fetal spina bifida (fSB) is the most common neural tube defect, and intrauterine repair has become a valid treatment option for selected cases. If fSB repair is offered, the ideal time for surgery is from 24 to 26 gestational weeks (GWs). The preoperative steroids for lung maturation and preoperative tocolytics that are administered are known to increase the prevalence of gestational diabetes (GD), which normally occurs in about 10-15% of all pregnant women. This study assessed the prevalence, possible influencing factors, and consequences on the course of pregnancy regarding GD in this cohort. Between 2010 and 2022, 184 fSB cases were operated. Those patients operated on after 24 0/7 GWs received steroids before surgery. All the patients received tocolysis, and an oral glucose tolerance test was performed between 26 and 28 GWs at least 7 days after steroid administration. In 2020, we established an early postoperative mobilization protocol. The perioperative management procedures of those patients with and without GD were compared to each other, and also, the patients treated according to the early mobilization protocol were compared to the remaining cohort. Nineteen percent were diagnosed with GD. Corticosteroids were administered in 92%. Neither the corticoid administration nor the interval between the administration and glucose tolerance test was different in patients with or without GD. Further, 99.5% received postoperative tocolytics for at least 48 h. The women with GD had significantly longer administration of tocolytics. The length of stay (LOS) was higher in those patients with GD. The gestational age (GA) at delivery was significantly lower in the cohort with GD. In the early mobilized group, we found a significantly higher GA at delivery (37.1 GWs vs. 36.2 GWs, = 0.009) and shorter LOS ( < 0.001), and their GD rate was lower (10% vs. 20%), although not statistically significant. The GD incidence in the women after fSB repair was higher than in the usual pregnant population. Early mobilization, rapid tocolytics decrease, and shorter LOS could benefit the pregnancy course after fSB repair and may decrease the risk for GD in this already high-risk cohort without increasing the risk for preterm delivery.
胎儿脊柱裂(fSB)是最常见的神经管缺陷,宫内修复已成为部分病例的有效治疗选择。如果提供fSB修复,理想的手术时间是妊娠24至26周(GWs)。已知用于促进肺成熟的术前类固醇和术前使用的宫缩抑制剂会增加妊娠期糖尿病(GD)的患病率,GD通常发生在约10%至15%的所有孕妇中。本研究评估了该队列中GD的患病率、可能的影响因素以及对妊娠过程的影响。在2010年至2022年期间,对184例fSB病例进行了手术。那些在妊娠24 0/7周后接受手术的患者在术前接受了类固醇治疗。所有患者均接受了宫缩抑制治疗,并在类固醇给药后至少7天的妊娠26至28周期间进行了口服葡萄糖耐量试验。2020年,我们制定了术后早期活动方案。比较了有和没有GD的患者的围手术期管理程序,并且还将根据早期活动方案治疗的患者与其余队列进行了比较。19%的患者被诊断为GD。92%的患者使用了皮质类固醇。有或没有GD的患者在皮质类固醇给药以及给药与葡萄糖耐量试验之间的间隔方面没有差异。此外,99.5%的患者术后接受了至少48小时的宫缩抑制剂治疗。患有GD的女性接受宫缩抑制剂治疗的时间明显更长。患有GD的患者住院时间(LOS)更长。患有GD的队列中分娩时的孕周(GA)明显更低。在早期活动组中,我们发现分娩时的GA明显更高(37.1周与36.2周, = 0.009)且LOS更短(< 0.001),并且她们的GD率更低(10%对20%),尽管没有统计学意义。fSB修复术后女性的GD发病率高于普通孕妇群体。早期活动、快速减少宫缩抑制剂使用以及缩短LOS可能有益于fSB修复后的妊娠过程,并可能降低这个已经高危队列中GD的风险,而不会增加早产风险。